Generation 4 Bone Cement
Bone Cement. 510(k) K993836, from Biomet, Inc. (Warsaw, IN). Product code LOD, class 2.
As of Nov 19, 2026, K993836 is an FDA 510(k) held by Biomet, Inc., substantially equivalent on Dec 19, 2001 after 768 days, with no recalls tied to it in FDA's recall database.
- Review time: 768 days
- Recalls: 0
- Cited as a predicate by: 2 devices
GENERATION 4 Bone Cement is indicated for the fixation of prostheses to living bone in orthopedic musculoskeletal surgical procedures for osteoarthritis, rheumatoid arthritis, traumatic arthritis, osteoporosis, avascular necrosis, collagen disease, severe joint destruction secondary to trauma or other conditions and revision of previous arthroplasty procedures.
- Cobalt G HV Bone CementK051532 · Biomet, Inc. · Aug 3, 2005
- Cobalt Bone CementK051496 · Biomet, Inc. · Aug 4, 2005
- Refobacin Bone Cement R (110034355)K254107 · Biomet France · Apr 15, 2026
- SPECTRUM GV Bone CementK250760 · Osteoremedies, LLC · Apr 2, 2025
- Osteopal® VK241674 · Heraeus Medical GmbH · Dec 5, 2024
- SPECTRUM® GV Bone CementK231556 · Osteoremedies, LLC · Dec 20, 2023
- Bone Cement Genta, Bone Cement HV, Bone Cement LVK211163 · Tecres S.P.A. · Jan 9, 2023
- Bone Cement-Normal ViscosityK212729 · Biomecanica Industria E Comerciode Produtos Ortopedicos Ltda · May 31, 2022
- OGM 1 Polymethylmethacrylate (PMMA) bone cement, OGM 1A Polymethylmethacrylate (PMMA) bone cementK211869 · Ormed Grup Medikal Turizm Saglik Hizmetleri Sanayi VE · May 19, 2022
- PALACOS MV proK213812 · Heraeus Medical GmbH · Feb 2, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Nov 12, 1999
- Review panel
- Orthopedic
- Regulation
- 21 CFR 888.3027
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files